• 801 Citations
  • 12 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Angela Cheng-Lai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Cardiovascular Agents Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
Heart Failure Medicine & Life Sciences
rosiglitazone Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1998 2019

  • 801 Citations
  • 12 h-Index
  • 32 Article
  • 1 Review article
2 Citations (Scopus)

Heart Failure Postdischarge Clinic: A Pharmacist-led Approach to Reduce Readmissions

Al-Bawardy, R., Cheng-Lai, A., Prlesi, L., Assafin, M., Xu, S., Chen, K., Tandan, S., Aneke, C. S., Murthy, S. & Pina, I. L., Jan 1 2019, (Accepted/In press) In : Current Problems in Cardiology.

Research output: Contribution to journalArticle

Heart Failure
2 Citations (Scopus)

Comparison of Adherence to the 2013 ACC/AHA Cholesterol Guideline in a Teaching Versus Nonteaching Outpatient Clinic

Cheng-Lai, A., Snead, J., Ng, C., Verges, C. & Chung, P., Apr 1 2018, In : Annals of Pharmacotherapy. 52, 4, p. 338-344 7 p.

Research output: Contribution to journalArticle

American Heart Association
Ambulatory Care Facilities
4 Citations (Scopus)

Celiprolol: A Unique Selective Adrenoceptor Modulator

Nawarskas, J. J., Cheng-Lai, A. & Frishman, W. H., 2017, In : Cardiology in Review. 25, 5, p. 247-253 7 p.

Research output: Contribution to journalArticle

Adrenergic Receptors
Ehlers-Danlos Syndrome
Blood Vessels
Mechanical Stress
6 Citations (Scopus)

Inhaled Insulin: A Clinical and Historical Review

Chan, J. & Cheng-Lai, A., 2017, In : Cardiology in Review. 25, 3, p. 140-146 7 p.

Research output: Contribution to journalReview article

Insulin Aspart

Edoxaban: A Novel Factor Xa Inhibitor for the Management of Non-Valvular Atrial Fibrillation and Venous Thromboembolism

Kubli, K. A., Snead, J. A. & Cheng-Lai, A., Mar 14 2016, (Accepted/In press) In : Cardiology in Review.

Research output: Contribution to journalArticle

Venous Thromboembolism
Atrial Fibrillation